Nivolumab: Promising Survival Signal Coupled with Limited Toxicity Raises Expectations

from Journal of Clinical Oncology (JCO) Podcast

This JCO podcast provides observations and commentary on the JCO article, Survival, Durable Tumor Remission, and Long-Term Safety in Patients with Advanced Melanoma Receiving Nivolumab," by Suzanne Topalian, et al.

Episode metadata supplied by the publisher feed · Published Mar 3, 2014

Embed this episode

Attribution link and audio player

NOW PLAYING

Nivolumab: Promising Survival Signal Coupled with Limited Toxicity Raises Expectations

0:00 10:30

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Journal of Clinical Oncology (JCO) Podcast?

This episode is 10 minutes long.

When was this Journal of Clinical Oncology (JCO) Podcast episode published?

This episode was published on March 3, 2014.

Can I download this Journal of Clinical Oncology (JCO) Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!